<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group>
<journal-title>PLoS ONE</journal-title></journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, USA</publisher-loc></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PONE-D-13-39020</article-id>
<article-id pub-id-type="doi">10.1371/journal.pone.0086972</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biology</subject><subj-group><subject>Computational biology</subject><subj-group><subject>Population genetics</subject><subj-group><subject>Genetic polymorphism</subject></subj-group></subj-group></subj-group><subj-group><subject>Evolutionary biology</subject><subj-group><subject>Population genetics</subject><subj-group><subject>Genetic polymorphism</subject></subj-group></subj-group></subj-group><subj-group><subject>Genetics</subject><subj-group><subject>Population genetics</subject><subj-group><subject>Genetic polymorphism</subject></subj-group></subj-group></subj-group><subj-group><subject>Population biology</subject><subj-group><subject>Population genetics</subject><subj-group><subject>Genetic polymorphism</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine</subject><subj-group><subject>Endocrinology</subject></subj-group><subj-group><subject>Epidemiology</subject><subj-group><subject>Genetic epidemiology</subject></subj-group></subj-group><subj-group><subject>Obstetrics and gynecology</subject></subj-group><subj-group><subject>Oncology</subject><subj-group><subject>Cancers and neoplasms</subject><subj-group><subject>Gynecological tumors</subject><subj-group><subject>Ovarian cysts</subject></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Association between Fat Mass- and Obesity- Associated (FTO) Gene Polymorphism and Polycystic Ovary Syndrome: A Meta-Analysis</article-title>
<alt-title alt-title-type="running-head">FTO Variant and PCOS</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple"><name name-style="western"><surname>Cai</surname><given-names>Xianli</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple"><name name-style="western"><surname>Liu</surname><given-names>Chibo</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mou</surname><given-names>Sihua</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib>
</contrib-group>
<aff id="aff1"><label>1</label><addr-line>Department of Gynaecology, Taizhou Municipal Hospital, Taizhou, China</addr-line></aff>
<aff id="aff2"><label>2</label><addr-line>Department of Clinical Laboratory, Taizhou Municipal Hospital, Taizhou, China</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple"><name name-style="western"><surname>Franks</surname><given-names>Stephen</given-names></name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/></contrib>
</contrib-group>
<aff id="edit1"><addr-line>Imperial College London, United Kingdom</addr-line></aff>
<author-notes>
<corresp id="cor1">* E-mail: <email xlink:type="simple">sihuamou@163.com</email></corresp>
<fn fn-type="conflict"><p>The authors have declared that no competing interests exist.</p></fn>
<fn fn-type="con"><p>Conceived and designed the experiments: SM. Performed the experiments: XC CL. Analyzed the data: CL. Contributed reagents/materials/analysis tools: XC CL. Wrote the paper: XC.</p></fn>
</author-notes>
<pub-date pub-type="collection"><year>2014</year></pub-date>
<pub-date pub-type="epub"><day>22</day><month>1</month><year>2014</year></pub-date>
<volume>9</volume>
<issue>1</issue>
<elocation-id>e86972</elocation-id>
<history>
<date date-type="received"><day>21</day><month>9</month><year>2013</year></date>
<date date-type="accepted"><day>19</day><month>12</month><year>2013</year></date>
</history>
<permissions>
<copyright-year>2014</copyright-year>
<copyright-holder>Cai et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions>
<abstract><sec>
<title>Aims</title>
<p>Many studies have investigated the relationship between <italic>FTO</italic> gene polymorphism and polycystic ovary syndrome (PCOS) susceptibility but revealed mixed results. In this study, we aimed to perform a meta-analysis to clarify this association.</p>
</sec><sec>
<title>Methods</title>
<p>Published literature from PubMed, Embase and CNKI was retrieved. Meta-analysis was performed to calculate pooled odds ratio (OR) with 95% confidence interval (CI) using the random- or fix- effects model.</p>
</sec><sec>
<title>Results</title>
<p>A total of 5 studies (4778 cases and 4272 controls) were included in our meta-analysis. The results suggested that <italic>FTO</italic> rs9939609 polymorphism (or its proxy) was marginally associated with PCOS risk after adjustment for body mass index (BMI) (OR = 1.26; 95%CI: 1.02–1.55). However, the marginal association was not stable after sensitivity analysis. In the subgroup analysis by ethnicity, the association was significant in East Asians (OR = 1.43, 95%CI = 1.30–1.59) but not in Caucasians (OR = 1.04, 95%CI = 0.85–1.29).</p>
</sec><sec>
<title>Conclusions</title>
<p>Our present meta-analysis indicated that <italic>FTO</italic> rs9939609 polymorphism (or its proxy) might not be associated with risk of PCOS in overall population. However, in East Asians, there might be a direct association between <italic>FTO</italic> variant and PCOS risk, which is independent of BMI (adiposity).</p>
</sec></abstract>
<funding-group><funding-statement>The authors have no support or funding to report.</funding-statement></funding-group><counts><page-count count="5"/></counts></article-meta>
</front>
<body><sec id="s1">
<title>Introduction</title>
<p>Polycystic ovary syndrome (PCOS) is a common endocrine disorder affecting 5–7% of women of childbearing age <xref ref-type="bibr" rid="pone.0086972-Asuncin1">[1]</xref>–<xref ref-type="bibr" rid="pone.0086972-Balen1">[3]</xref>. It is characterized by hirsutism, anovulation, clinical and/or biochemical hyperandrogenism, and polycystic ovarian morphology on ultrasound <xref ref-type="bibr" rid="pone.0086972-Rotterdam1">[4]</xref>. A large number of women with PCOS also exhibit insulin resistance, β-cell dysfunction, impaired glucose tolerance and/or type 2 diabetes <xref ref-type="bibr" rid="pone.0086972-Saxena1">[5]</xref>. It has been reported that about half of PCOS women are overweight or obese <xref ref-type="bibr" rid="pone.0086972-Clement1">[6]</xref> and obesity plays an important role in the etiology of PCOS <xref ref-type="bibr" rid="pone.0086972-Shi1">[7]</xref>–<xref ref-type="bibr" rid="pone.0086972-Tan1">[9]</xref>. Given the high prevalence of obesity in PCOS, both diseases may share similar genetic background <xref ref-type="bibr" rid="pone.0086972-Tan1">[9]</xref>. PCOS is a highly complex and heterogeneous disorder. So far, the pathogenesis of PCOS is still incompletely understood, it may be affected by the environmental or genetic factors, or their interactions.</p>
<p>The fat mass and obesity associated gene (<italic>FTO</italic>), located in chromosome 16q12.2 and expressed in the adipose tissue and the brain and muscles, was proved to associate with body mass index and obesity <xref ref-type="bibr" rid="pone.0086972-Frayling1">[10]</xref>. The <italic>FTO</italic> protein regulates energy metabolism to increase the obesity risk <xref ref-type="bibr" rid="pone.0086972-Willer1">[11]</xref>.</p>
<p>Up to date, several studies have been performed to investigate the association between <italic>FTO</italic> gene polymorphism and the PCOS susceptibility. Some studies reported that <italic>FTO</italic> rs9939609 polymorphism (or its proxies) was positively associated with PCOS <xref ref-type="bibr" rid="pone.0086972-Yan1">[12]</xref>–<xref ref-type="bibr" rid="pone.0086972-Li1">[16]</xref>, while others showed no significant association <xref ref-type="bibr" rid="pone.0086972-Ewens1">[17]</xref>–<xref ref-type="bibr" rid="pone.0086972-Kim1">[19]</xref>. The differences may be due to many factors, including the insufficient statistical power and whether adjustment for body mass index (BMI) in each individual study.</p>
<p>In order to increase the statistical power of individual studies, we performed a meta-analysis to clarify the relationship between <italic>FTO</italic> gene polymorphism and the risk of PCOS across different ethnic populations.</p>
</sec><sec id="s2" sec-type="methods">
<title>Methods</title>
<sec id="s2a">
<title>Literature and search strategy</title>
<p>We searched the PubMed, Embase and CNKI databases from 2007 to 2013 since <italic>FTO</italic> gene rs9939069 polymorphism and its association with obesity was first reported in 2007. The search strategy to identify all potential studies involved the use of the following key words: (PCOS OR polycystic ovary syndrome) and (fat mass and obesity associated gene OR <italic>FTO</italic>). The publication language was restricted to English or Chinese. The reference lists of retrieved articles were hand-searched. If more than one article were published using the same case series, only the study with largest sample size was included.</p>
</sec><sec id="s2b">
<title>Inclusion criteria and data extraction</title>
<p>A study was included in the meta-analysis only if it met all the following inclusion criteria: (1) evaluated the association of any of the <italic>FTO</italic> polymorphisms with PCOS; (2) used case-control or cohort design; (3) provided OR with 95%CI or sufficient data for calculation of the estimate. The following information was extracted from each study: (1) name of the first author; (2) year of publication; (3) origin of country; (4) ethnicity; (5) number of cases and controls; (6) mean age and BMI of subjects; (7) OR with 95% CI under an additive model; (8) single nucleotide polymorphisms (SNPs); and (9) <italic>P</italic> value for Hardy-Weinberg equilibrium (HWE) test in controls. Two authors independently assessed the articles for compliance with the inclusion/exclusion criteria, and resolved discrepancies by group discussion until reaching a consistent decision.</p>
</sec><sec id="s2c">
<title>Statistical analysis</title>
<p>The association of <italic>FTO</italic> polymorphism with PCOS was estimated by calculating the pooled OR and 95% CI. The significance of the pooled OR was determined by Z test (<italic>P</italic>&lt;0.05 was considered statistically significant). The Q test was performed to evaluate to the degree of between-study heterogeneity. A random-effects (DerSimonian–Laird) <xref ref-type="bibr" rid="pone.0086972-DerSimonian1">[20]</xref> or fixed-effects (Mantel–Haenszel) <xref ref-type="bibr" rid="pone.0086972-Mantel1">[21]</xref> model was used to calculate the pooled OR in the presence (<italic>P</italic>≤0.10) or absence (<italic>P</italic>&gt;0.10) of heterogeneity, respectively. Publication bias was assessed by Begg's test<xref ref-type="bibr" rid="pone.0086972-Begg1">[22]</xref> and Egger's test <xref ref-type="bibr" rid="pone.0086972-Egger1">[23]</xref> (<italic>P</italic>&lt;0.05 was considered statistically significant). To evaluate the stability of the results, we performed a sensitivity analysis by removing one study at a time. Data were analyzed by STATA version 11.0 (StataCorp LP, College Station, TX, USA).</p>
</sec></sec><sec id="s3">
<title>Results</title>
<sec id="s3a">
<title>Characteristics of the included studies</title>
<p>The literature search identified a total of 38 potentially relevant articles. Of these, 24 were excluded after reading the title or abstract because of obvious irrelevance, 13 potentially relevant articles remained for further full-text evaluation. Of these, 2 articles <xref ref-type="bibr" rid="pone.0086972-Tan1">[9]</xref>, <xref ref-type="bibr" rid="pone.0086972-Wehr1">[24]</xref> were excluded because they were within-patient study. One article <xref ref-type="bibr" rid="pone.0086972-Kowalska1">[25]</xref> was excluded because of lacking data for calculation of OR with 95% CI. One article <xref ref-type="bibr" rid="pone.0086972-Ewens1">[17]</xref> was excluded because it was a family-based study. 2 articles <xref ref-type="bibr" rid="pone.0086972-Wojciechowski1">[28]</xref>, <xref ref-type="bibr" rid="pone.0086972-Kosova1">[29]</xref> were excluded as they were reviews. One article was excluded since the number of cases was less than 50 <xref ref-type="bibr" rid="pone.0086972-Gu1">[13]</xref>. Two studies were excluded as both did not adjust for BMI which is one of the main confounding factors for the association <xref ref-type="bibr" rid="pone.0086972-Attaoua1">[14]</xref>, <xref ref-type="bibr" rid="pone.0086972-Barber1">[15]</xref>. At last, a total of 5 studies (4778 cases and 4272 controls) were included in our meta-analysis. A flow chart describing the process of study inclusion/exclusion is displayed as <xref ref-type="fig" rid="pone-0086972-g001">Figure 1</xref>.</p>
<fig id="pone-0086972-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0086972.g001</object-id><label>Figure 1</label><caption>
<title>Flow chart of article selection for meta-analysis.</title>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0086972.g001" position="float" xlink:type="simple"/></fig>
<p>All included studies used the Rotterdam criteria <xref ref-type="bibr" rid="pone.0086972-The1">[26]</xref> to diagnose PCOS except for the study by Saxena et al. <xref ref-type="bibr" rid="pone.0086972-Saxena1">[5]</xref> used the NIH criteria <xref ref-type="bibr" rid="pone.0086972-Welt1">[27]</xref>. The genotypes in the controls of all included studies were in Hardy-Weinberg equilibrium. Of these studies, there were 3 studies for rs9939609 <xref ref-type="bibr" rid="pone.0086972-Saxena1">[5]</xref>, <xref ref-type="bibr" rid="pone.0086972-Yan1">[12]</xref>, <xref ref-type="bibr" rid="pone.0086972-Li1">[16]</xref>, one study <xref ref-type="bibr" rid="pone.0086972-Kim1">[19]</xref> for rs1421085, one study <xref ref-type="bibr" rid="pone.0086972-Hatziagelaki1">[18]</xref> for rs8050136. Since rs9939609 was in high LD with rs1421085, rs8050136 (all r<sup>2</sup>&gt;0.90), we selected the rs9939609 polymorphism as the representative. Two ethnicities were involved in our 5 studies: 2 studies <xref ref-type="bibr" rid="pone.0086972-Saxena1">[5]</xref>, <xref ref-type="bibr" rid="pone.0086972-Hatziagelaki1">[18]</xref> were on Caucasian population, 3 studies <xref ref-type="bibr" rid="pone.0086972-Yan1">[12]</xref>, <xref ref-type="bibr" rid="pone.0086972-Li1">[16]</xref>, <xref ref-type="bibr" rid="pone.0086972-Kim1">[19]</xref> were on East Asian population. ORs and 95%CIs for the majority of studies were generated under an additive genetic model, so we calculated the summary estimate under this model. Characteristics of the included studies are shown in <xref ref-type="table" rid="pone-0086972-t001">Table 1</xref>.</p>
<table-wrap id="pone-0086972-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0086972.t001</object-id><label>Table 1</label><caption>
<title>Characteristics of studies included in meta-analysis.</title>
</caption><alternatives><graphic id="pone-0086972-t001-1" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0086972.t001" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1">Study</td>
<td align="left" rowspan="1" colspan="1">publication year</td>
<td align="left" rowspan="1" colspan="1">Country</td>
<td align="left" rowspan="1" colspan="1">Ethnicity</td>
<td align="left" rowspan="1" colspan="1"><italic>FTO</italic> SNP</td>
<td colspan="2" align="left" rowspan="1">Sample size</td>
<td colspan="2" align="left" rowspan="1">Mean age(years)</td>
<td colspan="2" align="left" rowspan="1">Mean BMI(kg/m<sup>2</sup>)</td>
<td align="left" rowspan="1" colspan="1">OR</td>
<td align="left" rowspan="1" colspan="1">95%CI</td>
<td align="left" rowspan="1" colspan="1"><italic>P</italic><sub>HWE</sub> <xref ref-type="table-fn" rid="nt102">a</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">cases</td>
<td align="left" rowspan="1" colspan="1">controls</td>
<td align="left" rowspan="1" colspan="1">cases</td>
<td align="left" rowspan="1" colspan="1">controls</td>
<td align="left" rowspan="1" colspan="1">cases</td>
<td align="left" rowspan="1" colspan="1">controls</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Yan et al. <xref ref-type="bibr" rid="pone.0086972-Yan1">[12]</xref></td>
<td align="left" rowspan="1" colspan="1">2009</td>
<td align="left" rowspan="1" colspan="1">China</td>
<td align="left" rowspan="1" colspan="1">East Asian</td>
<td align="left" rowspan="1" colspan="1">rs9939609</td>
<td align="left" rowspan="1" colspan="1">215</td>
<td align="left" rowspan="1" colspan="1">227</td>
<td align="left" rowspan="1" colspan="1">21.7</td>
<td align="left" rowspan="1" colspan="1">27.5</td>
<td align="left" rowspan="1" colspan="1">28.0</td>
<td align="left" rowspan="1" colspan="1">20.8</td>
<td align="left" rowspan="1" colspan="1">1.39</td>
<td align="left" rowspan="1" colspan="1">0.76–2.52</td>
<td align="left" rowspan="1" colspan="1">0.36</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Hatziagelaki et al.<xref ref-type="bibr" rid="pone.0086972-Hatziagelaki1">[18]</xref></td>
<td align="left" rowspan="1" colspan="1">2012</td>
<td align="left" rowspan="1" colspan="1">Germany</td>
<td align="left" rowspan="1" colspan="1">Caucasian</td>
<td align="left" rowspan="1" colspan="1">rs8050136</td>
<td align="left" rowspan="1" colspan="1">62</td>
<td align="left" rowspan="1" colspan="1">105</td>
<td align="left" rowspan="1" colspan="1">26.0</td>
<td align="left" rowspan="1" colspan="1">27.0</td>
<td align="left" rowspan="1" colspan="1">27.3</td>
<td align="left" rowspan="1" colspan="1">26.6</td>
<td align="left" rowspan="1" colspan="1">1.24</td>
<td align="left" rowspan="1" colspan="1">0.58–2.64</td>
<td align="left" rowspan="1" colspan="1">0.49</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Kim et al. <xref ref-type="bibr" rid="pone.0086972-Kim1">[19]</xref></td>
<td align="left" rowspan="1" colspan="1">2012</td>
<td align="left" rowspan="1" colspan="1">Korea</td>
<td align="left" rowspan="1" colspan="1">East Asian</td>
<td align="left" rowspan="1" colspan="1">rs1421085</td>
<td align="left" rowspan="1" colspan="1">377</td>
<td align="left" rowspan="1" colspan="1">386</td>
<td align="left" rowspan="1" colspan="1">28.5</td>
<td align="left" rowspan="1" colspan="1">28.5</td>
<td align="left" rowspan="1" colspan="1">22.2</td>
<td align="left" rowspan="1" colspan="1">20.1</td>
<td align="left" rowspan="1" colspan="1">1.13</td>
<td align="left" rowspan="1" colspan="1">0.47–2.68</td>
<td align="left" rowspan="1" colspan="1">0.46</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Saxena et al.<xref ref-type="bibr" rid="pone.0086972-Saxena1">[5]</xref></td>
<td align="left" rowspan="1" colspan="1">2012</td>
<td align="left" rowspan="1" colspan="1">USA</td>
<td align="left" rowspan="1" colspan="1">Caucasian</td>
<td align="left" rowspan="1" colspan="1">rs9939609</td>
<td align="left" rowspan="1" colspan="1">525</td>
<td align="left" rowspan="1" colspan="1">472</td>
<td align="left" rowspan="1" colspan="1">28.4</td>
<td align="left" rowspan="1" colspan="1">28.9</td>
<td align="left" rowspan="1" colspan="1">30.8</td>
<td align="left" rowspan="1" colspan="1">23.5</td>
<td align="left" rowspan="1" colspan="1">1.03</td>
<td align="left" rowspan="1" colspan="1">0.83–1.28</td>
<td align="left" rowspan="1" colspan="1">0.69</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Li et al. <xref ref-type="bibr" rid="pone.0086972-Li1">[16]</xref></td>
<td align="left" rowspan="1" colspan="1">2013</td>
<td align="left" rowspan="1" colspan="1">China</td>
<td align="left" rowspan="1" colspan="1">East Asian</td>
<td align="left" rowspan="1" colspan="1">rs9939609</td>
<td align="left" rowspan="1" colspan="1">3599</td>
<td align="left" rowspan="1" colspan="1">3082</td>
<td align="left" rowspan="1" colspan="1">28.4</td>
<td align="left" rowspan="1" colspan="1">31.3</td>
<td align="left" rowspan="1" colspan="1">24.8</td>
<td align="left" rowspan="1" colspan="1">22.7</td>
<td align="left" rowspan="1" colspan="1">1.44</td>
<td align="left" rowspan="1" colspan="1">1.30–1.60</td>
<td align="left" rowspan="1" colspan="1">0.74</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt101"><label/><p>OR =  odds ratio, CI =  confidence interval, SNP = single nucleotide polymorphism.</p></fn><fn id="nt102"><label>a</label><p><italic>P</italic> value for Hardy–Weinberg equilibrium test (HWE) in controls.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3b">
<title>Meta-analysis results</title>
<p>The overall result showed a marginal association between <italic>FTO</italic> rs9939609 polymorphism (or its proxies) and PCOS risk under an additive model after adjustment for BMI (OR = 1.26; 95%CI: 1.02–1.55; <xref ref-type="fig" rid="pone-0086972-g002">Figure 2</xref>), with modest evidence of between-study heterogeneity (<italic>I</italic><sup>2</sup> = 48.0%; <italic>p</italic> = 0.103). Since the study by Li et al. <xref ref-type="bibr" rid="pone.0086972-Li1">[16]</xref> made up the largest proportion (45.6%) of all included studies, we excluded this study and re-calculated the pooled estimate. The result suggested that the marginal association completed disappeared (OR = 1.08, 95%CI = 0.89–1.31).</p>
<fig id="pone-0086972-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0086972.g002</object-id><label>Figure 2</label><caption>
<title>Forest plot of meta-analysis of the association between rs9939609 (or its proxy) and PCOS after adjusted for BMI under an additive model.</title>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0086972.g002" position="float" xlink:type="simple"/></fig>
<p>In the subgroup analysis by ethnicity, the association after adjustment for BMI was significant in East Asians (OR = 1.43, 95%CI = 1.30–1.59) but not in Caucasians (OR = 1.04, 95%CI = 0.85–1.29).</p>
</sec><sec id="s3c">
<title>Sensitivity analysis</title>
<p>Sensitivity analysis was performed by removing one study at a time. The marginal association after adjustment for BMI was not stable, with ORs and 95%CIs ranging from 1.08 (0.89–1.31) to 1.43 (1.29–1.58).</p>
</sec><sec id="s3d">
<title>Publication bias</title>
<p>The results suggested no publication bias after adjustment for BMI (Egger's test: <italic>p</italic> = 0.462 and Begg's test: <italic>p</italic> = 0.479).</p>
</sec></sec><sec id="s4">
<title>Discussion</title>
<p>The present meta-analysis suggested that the <italic>FTO</italic> gene polymorphism was marginally associated with an increased risk of PCOS after adjustment for BMI. However, the marginal association was not stable in the sensitivity analysis. In the subgroup analysis, the association was significant in East Asians but not in Caucasians, suggesting the different ethnic effect on the association.</p>
<p>Up to now, the mechanism underlying the association of the <italic>FTO</italic> gene polymorphism with PCOS risk remains unclear. One recent meta-analysis suggested that the effect of <italic>FTO</italic> polymorphism on obesity-related traits in PCOS seems to be more than two times greater than the effect found in large population-based studies <xref ref-type="bibr" rid="pone.0086972-Wojciechowski1">[28]</xref>. Our meta-analysis showed that the association with PCOS disappeared after adjustment for BMI, indicating that the association between <italic>FTO</italic> gene rs9939609 polymorphism with PCOS susceptibility is probably by its effect on adiposity. This indirect mechanism was supported by the evidence that the effect estimates got far weaker when limited to the leaner PCOS patients in case-control study <xref ref-type="bibr" rid="pone.0086972-Barber1">[15]</xref>. The effect of <italic>FTO</italic> gene on obesity is mainly by increasing energy intake <xref ref-type="bibr" rid="pone.0086972-Timpson1">[30]</xref> and reducing satiety sensation<xref ref-type="bibr" rid="pone.0086972-Wardle1">[31]</xref>. In addition, <italic>FTO</italic> gene variation might influence the baseline lipid oxidation to increase the obesity risk in PCOS <xref ref-type="bibr" rid="pone.0086972-Kowalska1">[25]</xref>.</p>
<p>At present, it has been reported that <italic>FTO</italic> gene influence PCOS mainly via the association with obesity or obesity-related parameters<xref ref-type="bibr" rid="pone.0086972-Tan1">[9]</xref>, <xref ref-type="bibr" rid="pone.0086972-Yan1">[12]</xref>, <xref ref-type="bibr" rid="pone.0086972-Attaoua1">[14]</xref>, <xref ref-type="bibr" rid="pone.0086972-Barber1">[15]</xref>, <xref ref-type="bibr" rid="pone.0086972-Wehr1">[24]</xref>, <xref ref-type="bibr" rid="pone.0086972-Wardle1">[31]</xref>, such as BMI, body weight, fat mass and some other metabolism-related traits<xref ref-type="bibr" rid="pone.0086972-Tan1">[9]</xref>, <xref ref-type="bibr" rid="pone.0086972-Attaoua1">[14]</xref>, <xref ref-type="bibr" rid="pone.0086972-Wehr1">[24]</xref>, <xref ref-type="bibr" rid="pone.0086972-Kowalska2">[32]</xref>, such as insulin resistance, impaired fasting glucose, glucose intolerance. It has been reported that the impact of the <italic>FTO</italic> gene polymorphism on the metabolic parameters could be due to its effect on BMI <xref ref-type="bibr" rid="pone.0086972-Freathy1">[33]</xref>. The effect of the <italic>FTO</italic> gene on PCOS is possibly related to its genetic interaction with other susceptibility genes, and they combined to create the polygenic background of PCOS <xref ref-type="bibr" rid="pone.0086972-Kowalska2">[32]</xref>. Another direct mechanism might be that the inverse correlation between fat mass and sex hormone binding globulin (SHBG) levels in women may result in lower SHBG levels in those with <italic>FTO</italic> risk allele, which in turn would lead to higher free testosterone <xref ref-type="bibr" rid="pone.0086972-Li2">[34]</xref>. In regards to indirect mechanism, insulin resistance and hyperinsulinaemia may increase in subjects with <italic>FTO</italic> risk allele, then resulting in hyperandrogenaemia throuh ovarian co-gonadotrophic effects <xref ref-type="bibr" rid="pone.0086972-DiamantiKandarakis1">[35]</xref>.</p>
<p>The current meta-analysis has some limitations in spite of several advantages compared to individual studies. First, some potential confounding factors or modifiers were not controlled for. For instance, two included studies did not provide BMI-adjusted data <xref ref-type="bibr" rid="pone.0086972-Attaoua1">[14]</xref>, <xref ref-type="bibr" rid="pone.0086972-Barber1">[15]</xref>. Second, the gene-gene/gene-environment interaction was not addressed in the current meta-analysis since no related data was provided by the original publications. Third, the underlying genetics may be quite different in subjects with different sub-phenotypes of PCOS. The criteria of Rotterdam Revised 2003 stated that subjects fulfilled the following 2 out of 3 items were diagnosed as PCOS: (i) oligomenorrhea or amenorrhea for at least 6 months; (ii) clinical and/or biochemical signs of hyperandrogenism; (iii) polycystic ovaries (the presence of 12 or more follicles in each ovary measuring 2–9 mm in diameter) and/or increased ovarian volume (&gt;10 ml) <xref ref-type="bibr" rid="pone.0086972-The1">[26]</xref>. However, nearly all the studies did not specify the number of subjects for each subset of phenotypes. Thus, the majority of included studies did not provide the data for sub-phenotypes of PCOS versus controls. Then, we were unable to examine the association between <italic>FTO</italic> variant and sub-phenotypes of PCOS.</p>
<p>In conclusions, our meta-analysis results indicated that <italic>FTO</italic> rs9939609 polymorphism (or its proxy) was not related to PCOS susceptibility after adjustment for BMI. However, in East Asians, there might be a direct association between <italic>FTO</italic> variant and PCOS risk since the association was significant after adjustment for BMI. Further studies should be conducted to explore the association of <italic>FTO</italic> gene polymorphism with PCOS.</p>
</sec></body>
<back><ref-list>
<title>References</title>
<ref id="pone.0086972-Asuncin1"><label>1</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Asunción</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Calvo</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>San Millán</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Sancho</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Avila</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2000</year>) <article-title>A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain</article-title>. <source>J Clin Endocrinol Metab</source> <volume>85</volume>: <fpage>2434</fpage>–<lpage>2438</lpage>.</mixed-citation>
</ref>
<ref id="pone.0086972-Legro1"><label>2</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Legro</surname><given-names>RS</given-names></name> (<year>2000</year>) <article-title>The genetics of obesity Lessons for polycystic ovary syndrome</article-title>. <source>Ann N Y Acad Sci</source> <volume>900</volume>: <fpage>193</fpage>–<lpage>202</lpage>.</mixed-citation>
</ref>
<ref id="pone.0086972-Balen1"><label>3</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Balen</surname><given-names>AH</given-names></name>, <name name-style="western"><surname>Conway</surname><given-names>GS</given-names></name>, <name name-style="western"><surname>Kaltsas</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Techatraisak</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Manning</surname><given-names>PJ</given-names></name>, <etal>et al</etal>. (<year>1995</year>) <article-title>Andrology: Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients[J]</article-title>. <source>Human Reproduction</source> <volume>10</volume>: <fpage>2107</fpage>–<lpage>2111</lpage>.</mixed-citation>
</ref>
<ref id="pone.0086972-Rotterdam1"><label>4</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rotterdam</surname></name> (<year>2004</year>) <article-title>Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)</article-title>. <source>Human reproduction (Oxford, England)</source>, <volume>19</volume>, <fpage>41</fpage>.</mixed-citation>
</ref>
<ref id="pone.0086972-Saxena1"><label>5</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Saxena</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Welt</surname><given-names>CK</given-names></name> (<year>2012</year>) <article-title>Polycystic ovary syndrome is not associated with genetic variants that mark risk of type 2 diabetes</article-title>. <source>Acta Diabetologica</source>. <comment>doi <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00592-012-0383-4" xlink:type="simple">10.1007/s00592-012-0383-4</ext-link></comment></mixed-citation>
</ref>
<ref id="pone.0086972-Clement1"><label>6</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Clement</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Sorensen</surname><given-names>TIA</given-names></name> (<year>2007</year>) <article-title>Obesity: genomics and postgenomics</article-title>. <source>Infoma Healthcare</source> <comment>pp</comment> <fpage>19</fpage>–<lpage>58</lpage>.</mixed-citation>
</ref>
<ref id="pone.0086972-Shi1"><label>7</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shi</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Guo</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Yan</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome</article-title>. <source>Neuroendocrinol Lett</source> <volume>28</volume>, <fpage>807</fpage>–<lpage>810</lpage>.</mixed-citation>
</ref>
<ref id="pone.0086972-Gambineri1"><label>8</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gambineri</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Pelusi</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Vicennati</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Pagotto</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Pasquali</surname><given-names>R</given-names></name> (<year>2002</year>) <article-title>Obesity and the polycystic ovary syndrome</article-title>. <source>Int. J. Obes. Relat. Metab. Disord</source> <volume>26</volume>, <fpage>883</fpage>–<lpage>896</lpage>.</mixed-citation>
</ref>
<ref id="pone.0086972-Tan1"><label>9</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tan</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Scherag</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Janssen</surname><given-names>OE</given-names></name>, <name name-style="western"><surname>Hahn</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Lahner</surname><given-names>H</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Large effects on body mass index and insulin resistance of fat mass and obesity associated gene (FTO) variants in patients with polycystic ovary syndrome (PCOS)</article-title>. <source>BMC Medical Genetics</source> <volume>11</volume>, <fpage>12</fpage>.</mixed-citation>
</ref>
<ref id="pone.0086972-Frayling1"><label>10</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Frayling</surname><given-names>TM</given-names></name>, <name name-style="western"><surname>Timpson</surname><given-names>NJ</given-names></name>, <name name-style="western"><surname>Weedon</surname><given-names>MN</given-names></name>, <name name-style="western"><surname>Zeggini</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Freathy</surname><given-names>RM</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity</article-title>. <source>Science</source> <volume>316</volume>, <fpage>889</fpage>–<lpage>894</lpage>.</mixed-citation>
</ref>
<ref id="pone.0086972-Willer1"><label>11</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Willer</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Speliotes</surname><given-names>EK</given-names></name>, <name name-style="western"><surname>Loos</surname><given-names>RJF</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Lindgren</surname><given-names>CM</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Six new loci associated with body mass index highlight a neuronal influence on body weight regulation</article-title>. <source>Nat Genet</source> <volume>41</volume>, <fpage>25</fpage>–<lpage>34</lpage>.</mixed-citation>
</ref>
<ref id="pone.0086972-Yan1"><label>12</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yan</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Hong</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Gu</surname><given-names>WQ</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>YF</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>QR</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Association of the common rs9939609 variant of FTO gene with polycystic ovary syndrome in Chinese women</article-title>. <source>Endocrine</source> <volume>36</volume>, <fpage>377</fpage>–<lpage>382</lpage>.</mixed-citation>
</ref>
<ref id="pone.0086972-Gu1"><label>13</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gu</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Tao</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Fan</surname><given-names>JX</given-names></name> (<year>2012</year>) <article-title>Polymorphism of fat mass and obesity associated gene in the placenta tissues from patients with polycystic ovarian syndrome</article-title>. <source>Chinese Journal of Clinical Medicine</source> <volume>19</volume>, <fpage>213</fpage>–<lpage>214</lpage>.</mixed-citation>
</ref>
<ref id="pone.0086972-Attaoua1"><label>14</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Attaoua</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Ait El Mkadem</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Radian</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Fica</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Hanzu</surname><given-names>F</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>FTO gene associates to metabolic syndrome in women with polycystic ovary syndrome</article-title>. <source>Biochemical and Biophysical Research Communications</source> <volume>22</volume>, <fpage>230</fpage>–<lpage>234</lpage>.</mixed-citation>
</ref>
<ref id="pone.0086972-Barber1"><label>15</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Barber</surname><given-names>TM</given-names></name>, <name name-style="western"><surname>Bennett</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Groves</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Sovio</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Ruokonen</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Association of variants in the fat mass and obesity associated (FTO) gene with polycystic ovary syndrome</article-title>. <source>Diabetologia</source> <volume>51</volume>, <fpage>1153</fpage>–<lpage>1158</lpage>.</mixed-citation>
</ref>
<ref id="pone.0086972-Li1"><label>16</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>KL</given-names></name>, <name name-style="western"><surname>You</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Xing</surname><given-names>XY</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>P</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Common Variant rs9939609 in Gene FTO Confers Risk to Polycystic Ovary Syndrome[J]</article-title>. <source>PloS one</source> <volume>8</volume>, <fpage>e66250</fpage>.</mixed-citation>
</ref>
<ref id="pone.0086972-Ewens1"><label>17</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ewens</surname><given-names>KG</given-names></name>, <name name-style="western"><surname>Jones</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Ankener</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Stewart</surname><given-names>DR</given-names></name>, <name name-style="western"><surname>Urbanek</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>FTO and MC4R gene variants are associated with obesity in polycystic ovary syndrome</article-title>. <source>PLoS ONE</source> <volume>6</volume>, <fpage>e16390</fpage>.</mixed-citation>
</ref>
<ref id="pone.0086972-Hatziagelaki1"><label>18</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hatziagelaki</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Wagner</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Kantartzis</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Heni</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Linder</surname><given-names>K</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Insulin Resistant Phenotype of Polycystic Ovary Syndrome does not Seem to be Caused by Variation in FTO</article-title>. <source>Hormone and Metabolic Research</source> <volume>44</volume>, <fpage>810</fpage>–<lpage>813</lpage>.</mixed-citation>
</ref>
<ref id="pone.0086972-Kim1"><label>19</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kim</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Choi</surname><given-names>YM</given-names></name>, <name name-style="western"><surname>Cho</surname><given-names>YM</given-names></name>, <name name-style="western"><surname>Hong</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Chae</surname><given-names>SJ</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Polycystic ovary syndrome is not associated with polymorphisms of the TCF7L2, CDKAL1,HHEX KCNJ11,FTO and SLC30A8 genes</article-title>. <source>Clinical Endocrinology</source> <volume>77</volume>, <fpage>439</fpage>–<lpage>445</lpage>.</mixed-citation>
</ref>
<ref id="pone.0086972-DerSimonian1"><label>20</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>DerSimonian</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Laird</surname><given-names>N</given-names></name> (<year>1986</year>) <article-title>Meta-analysis in clinical trials</article-title>. <source>Control Clin Trials</source> <volume>7</volume>, <fpage>177</fpage>–<lpage>188</lpage>.</mixed-citation>
</ref>
<ref id="pone.0086972-Mantel1"><label>21</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mantel</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Haenszel</surname><given-names>W</given-names></name> (<year>1959</year>) <article-title>Statistical aspects of the analysis of data from retrospective studies of disease</article-title>. <source>J Natl Cancer Inst</source> <volume>22</volume>, <fpage>719</fpage>–<lpage>748</lpage>.</mixed-citation>
</ref>
<ref id="pone.0086972-Begg1"><label>22</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Begg</surname><given-names>CB</given-names></name>, <name name-style="western"><surname>Mazumdar</surname><given-names>M</given-names></name> (<year>1994</year>) <article-title>Operating characteristics of a rank correlation test for publication bias</article-title>. <source>Biometrics</source> <volume>50</volume>, <fpage>1088</fpage>–<lpage>1101</lpage>.</mixed-citation>
</ref>
<ref id="pone.0086972-Egger1"><label>23</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Egger</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>GD</given-names></name>, <name name-style="western"><surname>Schneider</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Minder</surname><given-names>C</given-names></name> (<year>1997</year>) <article-title>Bias in meta-analysis detected by a simple, graphical test</article-title>. <source>BMJ</source> <volume>315</volume>, <fpage>629</fpage>–<lpage>634</lpage>.</mixed-citation>
</ref>
<ref id="pone.0086972-Wehr1"><label>24</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wehr</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Schweighofer</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Möller</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Giuliani</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Pieber</surname><given-names>TR</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Association of FTO gene with hyperandrogenemia and metabolic parameters in women with polycystic ovary syndrome</article-title>. <source>Metabolism</source> <volume>59</volume>, <fpage>575</fpage>–<lpage>580</lpage>.</mixed-citation>
</ref>
<ref id="pone.0086972-Kowalska1"><label>25</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kowalska</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Adamska</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Malecki</surname><given-names>MT</given-names></name>, <name name-style="western"><surname>Karczewska-Kupczewska</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Nikolajuk</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Impact of the FTO gene variation on fat oxidation and its potential influence on body weight in women with polycystic ovary syndrome</article-title>. <source>Clinical Endocrinology</source> <volume>77</volume>, <fpage>120</fpage>–<lpage>125</lpage>.</mixed-citation>
</ref>
<ref id="pone.0086972-The1"><label>26</label>
<mixed-citation publication-type="journal" xlink:type="simple"><collab xlink:type="simple">The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group</collab> (<year>2004</year>) <article-title>Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)</article-title>. <source>Hum Reprod</source> <volume>1</volume>, <fpage>41</fpage>–<lpage>47</lpage>.</mixed-citation>
</ref>
<ref id="pone.0086972-Welt1"><label>27</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Welt</surname><given-names>CK</given-names></name>, <name name-style="western"><surname>Arason</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Gudmundsson</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Adams</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Palsdóttir</surname><given-names>H</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Defining constant versus variable phenotypic features of women with polycystic ovary syndrome using different ethnic groups and populations</article-title>. <source>J Clin Endocrinol Metab</source> <volume>91</volume>, <fpage>4361</fpage>–<lpage>4368</lpage>.</mixed-citation>
</ref>
<ref id="pone.0086972-Wojciechowski1"><label>28</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wojciechowski</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Lipowska</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Rys</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Ewens</surname><given-names>KG</given-names></name>, <name name-style="western"><surname>Franks</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Impact of FTO genotypes on BMI and weight in polycystic ovary syndrome: a systematic review and meta-analysis</article-title>. <source>Diabetologia</source> <volume>55</volume>, <fpage>2636</fpage>–<lpage>2645</lpage>.</mixed-citation>
</ref>
<ref id="pone.0086972-Kosova1"><label>29</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kosova</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Urbanek</surname><given-names>M</given-names></name> (<year>2012</year>) <article-title>Genetics of the polycystic ovary syndrome</article-title>. <source>Molecular and Cellular Endocrinology</source>. <comment>doi.org/<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.mce.2012.10.00" xlink:type="simple">10.1016/j.mce.2012.10.00</ext-link></comment></mixed-citation>
</ref>
<ref id="pone.0086972-Timpson1"><label>30</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Timpson</surname><given-names>NJ</given-names></name>, <name name-style="western"><surname>Emmett</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Frayling</surname><given-names>TM</given-names></name>, <name name-style="western"><surname>Rogers</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Hattersley</surname><given-names>AT</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>The fat mass and obesity-associated locus and dietary intake in children</article-title>. <source>Am J Clin Nutr</source> <volume>88</volume>, <fpage>971</fpage>–<lpage>978</lpage>.</mixed-citation>
</ref>
<ref id="pone.0086972-Wardle1"><label>31</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wardle</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Carnell</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Haworth</surname><given-names>CMA</given-names></name>, <name name-style="western"><surname>Farooqi</surname><given-names>IS</given-names></name>, <name name-style="western"><surname>O'Rahilly</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Obesity associated genetic variation in FTO is associated with diminished satiety</article-title>. <source>Journal of Clinical Endocrinology &amp; Metabolism</source> <volume>93</volume>, <fpage>3640</fpage>–<lpage>3643</lpage>.</mixed-citation>
</ref>
<ref id="pone.0086972-Kowalska2"><label>32</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kowalska</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Malecki</surname><given-names>MT</given-names></name>, <name name-style="western"><surname>Straczkowski</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Skupien</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Karczewska-Kupczewska</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>The FTO gene modifies weight, fat mass and insulin sensitivity in women with polycystic ovary syndrome, where its role may be larger than in other phenotypes</article-title>. <source>Diabetes and Metabolism</source> <volume>35</volume>, <fpage>328</fpage>–<lpage>331</lpage>.</mixed-citation>
</ref>
<ref id="pone.0086972-Freathy1"><label>33</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Freathy</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Timpson</surname><given-names>NJ</given-names></name>, <name name-style="western"><surname>Lawlor</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Pouta</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ben-Shlomo</surname><given-names>Y</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Common variation in the FTO gene alters diabetes-related metabolic traits to the extent expected given its effect on BMI</article-title>. <source>Diabetes</source> <volume>57</volume>, <fpage>1419</fpage>–<lpage>1426</lpage>.</mixed-citation>
</ref>
<ref id="pone.0086972-Li2"><label>34</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Ford</surname><given-names>ES</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Giles</surname><given-names>WH</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>S</given-names></name> (<year>2010</year>) <article-title>Association of testosterone and sex hormone-binding globulin with metabolic syndrome and insulin resistance in men</article-title>. <source>Diabetes Care</source> <volume>33</volume>, <fpage>1618</fpage>–<lpage>1624</lpage>.</mixed-citation>
</ref>
<ref id="pone.0086972-DiamantiKandarakis1"><label>35</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Diamanti-Kandarakis</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Papavassiliou</surname><given-names>AG</given-names></name> (<year>2006</year>) <article-title>Molecular mechanisms of insulin resistance in polycystic ovary syndrome</article-title>. <source>Trends Mol Med</source> <volume>12</volume>, <fpage>324</fpage>–<lpage>332</lpage>.</mixed-citation>
</ref>
</ref-list></back>
</article>